| DIRECT COMPETITOR COMPARISON | |
| MHAN.OB | AMGN | JNJ | WCRX | Industry | | Market Cap: | 4.24M | 56.43B | 178.62B | 6.97B | 94.71M | | Employees: | 3 | 16,700 | 118,700 | 1,115 | 63 | | Qtrly Rev Growth (yoy): | N/A | -1.60% | -5.30% | 9.00% | 19.70% | | Revenue (ttm): | N/A | 14.58B | 60.53B | 992.09M | 13.84M | | Gross Margin (ttm): | N/A | 84.99% | 71.08% | 80.52% | 65.67% | | EBITDA (ttm): | -846.84K | 6.71B | 19.05B | 544.85M | -11.86M | | Oper Margins (ttm): | N/A | 38.71% | 26.94% | 30.52% | -137.11% | | Net Income (ttm): | -2.44M | 4.74B | 12.77B | 407.93M | N/A | | EPS (ttm): | -0.035 | 4.585 | 4.579 | 1.629 | -0.31 | | P/E (ttm): | N/A | 12.16 | 14.14 | 17.02 | 16.54 | | PEG (5 yr expected): | N/A | 1.31 | 1.91 | 1.17 | 1.27 | | P/S (ttm): | N/A | 3.95 | 2.96 | 6.94 | 9.78 |
|
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 55.75 | -1.95% | 56.43B | 12.16 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 49.43 | 1.15% | 14.30B | 16.54 | | Genzyme Corp. | GENZ | 49.25 | -1.46% | 13.07B | 28.08 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 45.31 | -3.51% | 40.78B | 17.52 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 51.49 | -0.25% | 9.18B | 1050.82 | | Teva Pharmaceutical Industries Limited | TEVA | 53.20 | -0.54% | 46.87B | 48.67 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 38.36 | -0.75% | 4.07B | 19.77 | | King Pharmaceuticals Inc. | KG | 11.87 | 0.25% | 2.95B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 19.04 | 1.44% | 5.82B | 116.81 | | Pfizer Inc. | PFE | 18.29 | -0.60% | 147.59B | 15.19 | | Johnson & Johnson | JNJ | 64.74 | -0.34% | 178.62B | 14.14 | | GlaxoSmithKline plc | GSK | 42.84 | -0.16% | 108.60B | 13.77 | | Sanofi-Aventis | SNY | 38.66 | -0.26% | 100.95B | N/A | | Novartis AG | NVS | 53.76 | -0.83% | 122.10B | 16.10 |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | RHHBY.PK | 40.85 | -0.37% | N/A | N/A | | AstraZeneca plc | AZN | 46.10 | 0.70% | 66.84B | 9.26 | | Abbott Laboratories | ABT | 53.99 | 0.39% | 83.51B | 14.63 | | Bristol-Myers Squibb Co. | BMY | 25.74 | -0.85% | 50.99B | 13.32 |
|
| NEWS ON DIRECT COMPETITORS | |
| • | JNJ | | REFILE-UPDATE - US Senate rejects drug imports under health bill
Tue 8:46pm -
at Reuters | | • | JNJ | | What Do Bill Gates, Warren Buffett, and You Have in Common?
Tue 7:00pm -
at Motley Fool | | • | AMGN | | Dow slides 49 points; Colorado’s Array BioPharma jumps on Amgen deal
Tue 6:05pm -
at bizjournals.com | | • | AMGN | | Best Buy, Wells Fargo, Qwest are big movers
Tue 5:27pm -
AP | | • | JNJ | | Whirlpool appoints former Wrigley CEO to board
Tue 4:44pm -
AP | | • | AMGN | | Equities Update: Stocks Finish Lower as Inflation Signs Emerge
Tue 4:30pm -
at Seeking Alpha | | • | JNJ | | Pfizer in China, AIDS Drugs in Africa, Vaccine Recall in U.S.
Tue 3:38pm -
at The Wall Street Journal Online | | • | JNJ | | Biotech Stocks: Elan, Gilead Sciences lead drug stocks lower
Tue 3:34pm -
at MarketWatch | | • | JNJ | | Forget the Higher Doses
Tue 3:16pm -
at Motley Fool | | • | WCRX | | How to Pick Stocks by Following Bonds: Portfolio Manager
Tue 2:17pm -
at CNBC | | • | AMGN | | Array BioPharma shares rise on Amgen deal
Tue 1:56pm -
AP | | • | AMGN | | It's Nice to Have Friends With Cash
Tue 1:10pm -
at Motley Fool | | • | AMGN | | UPDATE - Celgene psoriasis drug shows promise in trial
Tue 10:23am -
at Reuters | | • | WCRX | | InPlay: Warner Chilcott affirms global marketing and collaboration agreement with Sanofi-Aventis
Tue 9:03am -
Briefing.com | | • | WCRX | | Warner Chilcott Affirms Global Marketing and Collaboration Agreement With Sanofi-Aventis
Tue 9:00am -
PR Newswire | | • | WCRX | | WARNER CHILCOTT PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Fri, Dec 11 -
EDGAR Online | | • | WCRX | | Warner Chilcott Considers Potential Repurchase or Redemption of 8.75% Senior Subordinated Notes
Fri, Dec 11 -
PR Newswire | | | All Headlines for these symbols... |
|
|
|
0.47% Nasdaq 
Competitors
